Dr Nipun Verma
@drnipunverma
Followers
821
Following
3K
Media
155
Statuses
2K
Clinician hepatologist, devoted to patient care, research and teaching, #AI, #EBM, #infections #liver failure #Omics #statistics #one world one family
Pgimer chandigarh
Joined November 2023
🚩NOT only a novel prognostic index in acutely decompensated cirrhosis.. 📍Our study identifying novel therapeutic targets in AD and ACLF @HepatologyPGI @ajay_duseja @drsuniltaneja in collaboration with @ucl @RajivJalan1 Berlin Cornelius 🎯 RIPK3 🎯 https://t.co/A08KieGavj
7
22
71
IgG4-related Pseudotumor Masquerading as HCC 🔥 👉🏼Initially labelled as non-cirrhotic hepatocellular carcinoma 👉🏼Histopathology revealed: ⭕ Storiform fibrosis ⭕Lymphoplasmacytic infiltration ⭕Increased IgG4-positive plasma cells ⚡DOI: 10.1016/j.jceh.2025.103409⚡ 👉🏼Patient
2
5
13
"When the universe hugged you twice in 2 days" Humbled to receive the 1st 🏆 at Young Investigator Award, ISCON2025 Shoutout to my mentors, colleagues and the incredible team @apollo_kolkata 🙏🏽 @AnandVKulkarni2 @ajay_duseja @drsuniltaneja @docMPK @drnipunverma @DrMaheshgoenka
13
1
45
This week's EASL Studio episode is now available on demand! Catch up now: https://t.co/5YzsA0MVUu
@DebbieShawcros1 @saulkarpen @allisonkwong @NoureddinMD
#LiverTwitter #LiverX
0
2
4
Humbled to be awarded the OP Memorial Rising Star Award at ISGCON 2025. Moments like these rekindle why the journey is worth it. Grateful to all my mentors, colleagues and patients 🥂 to @AnandVKulkarni2 for winning the SR Nayak Researcher Award 🎗️Award twinning mode on✨
27
8
72
A meta-analysis shows that in liver disease due to alcohol use, psychosocial therapy reduces return-to-drinking by ~50%: 👉 Treating AUD in CLD is NOT just about prescribing pills. 👉 Psychosocial therapy + pharmacotherapy = best outcomes. Offer both ! https://t.co/Enl66kRowV
2
33
61
I just learned about Lactylation, an emerging epigenetic modification. In liver disease, excess lactate reshapes chromatin, driving fibrosis and tumor progression. It represent a new therapeutic target. A fascinating field to watch.
1
10
41
Lambert High School in Georgia was the only U.S. school to place in the high school top 10 at iGEM, an international synthetic biology competition. The other top teams included one from South Korea, one from Taiwan, and seven from China. https://t.co/1NfIKjbozP
65
253
1K
It was wonderful hosting you sir @amritafbd .. hoping to see you again soon!
Learning-filled & truly humbling experience 🙏 It was a privilege to be associated with @CAMO_Net1 and to present at @amritafbd, contributing in a small way to the fight against the rising epidemic of AMR 🧫🦠 Grateful for the opportunity and inspired to do more. 💪✨
0
1
5
Learning-filled & truly humbling experience 🙏 It was a privilege to be associated with @CAMO_Net1 and to present at @amritafbd, contributing in a small way to the fight against the rising epidemic of AMR 🧫🦠 Grateful for the opportunity and inspired to do more. 💪✨
0
1
6
🚨 Updated @BavenoCoop "Rule-of-5" Figure by the #ANTICIPATE ±NASH team 📕in @JHepatology 🔗 https://t.co/yy92JSulCj
1
37
85
@drnipunverma Congratulations sir.....Nice study with a well thought inclusion criteria. Curious why liposomal ampho B and not caspofungin was chosen as the intervention drug in the trial?
1
1
1
@drnipunverma @drsanthoshe @ICMRDELHI @HepatologyPGI @AmJGastro @AASLDtweets @AmerGastroAssn @EASLnews @EASLedu @INASL_Liver @APASLnews @BASLedu @LiverFellow @ajay_duseja @arunaloke2 @DrArunKValsan @Pratibha28Garg @drsuniltaneja @doc_arka @SahajRathi Well done and thank you for the work @drnipunverma
1
1
2
See you today 18:00 CET for an interactive EASL Studio on Rifaximin for Hepatic Encephalopathy, as we honour World Antimicrobial Awareness Week. 🔗 https://t.co/8g378Q0A0h
@DebbieShawcros1 @RajivJalan1 @DrVishalCPatel @JonelTrebicka
#LiverTwitter #LiverX
easl.eu
For World Antimicrobial Awareness Week 2025 (“Act Now: Protect Our Present, Secure Our Future”), this EASL Studio explores the balance between rifaximin’s benefits in hepatic encephalopathy and the...
0
3
6
Looking forward. The votes about use of Rifaximin is split. Let’s analyse the existing data. See u all there
See you today 18:00 CET for an interactive EASL Studio on Rifaximin for Hepatic Encephalopathy, as we honour World Antimicrobial Awareness Week. 🔗 https://t.co/8g378Q0A0h
@DebbieShawcros1 @RajivJalan1 @DrVishalCPatel @JonelTrebicka
#LiverTwitter #LiverX
0
1
5
@ebtapper @JasmohanBajaj @FungalUpdate @ID_fellows @mycologymycoses @IvaKosuta @ABsteward @AASLDtweets @EASLnews @EASLedu @APASLnews @BASLedu @INASL_Liver @WU_Mycoses @IPMC_Indonesia @CDC_NCEZID @AnandVKulkarni2 @RohitMehtaniDM @RoyAHep @drsanthoshe @drshalimar @DebbieShawcros1 @vinayjaha @IvaKosuta @salvatore_piano @ProfPaoloAngeli @ISHAM_Mycology @MRCcmm
0
2
7
👩⚕️👨⚕️ Hepatology, ICU & ID colleagues: Would you adopt an empirical-first strategy in your ACLF unit, or would you still wait for pre-emptive triggers? Curious to hear your views. 💬 @ebtapper @JasmohanBajaj @FungalUpdate @ID_fellows @mycologymycoses @IvaKosuta @ABsteward
1
1
3
🧵 on article from @ICMRDELHI Study @HepatologyPGI @AmJGastro Can early empirical antifungals really change outcomes in ACLF with suspected invasive fungal infection (IFI)? 🤔 @AASLDtweets @AmerGastroAssn @EASLnews @EASLedu @INASL_Liver @APASLnews @BASLedu @LiverFellow
5
11
30
New online! Regulated necrosis at the crossroads of liver inflammation and cancer development https://t.co/5AkvE7HgAE
0
20
57
👩⚕️👨⚕️ Hepatology, ICU & ID colleagues: Would you adopt an empirical-first strategy in your ACLF unit, or would you still wait for pre-emptive triggers? Curious to hear your views. 💬 @ebtapper @JasmohanBajaj @FungalUpdate @ID_fellows @mycologymycoses @IvaKosuta @ABsteward
1
1
3